Affiliated Cancer Hospital of Shantou University Medical College
4 clinical trials · Sponsor
◉ Watch Affiliated Cancer Hospital of Shantou University Medical College
| Record | Firm | Date |
|---|---|---|
| Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement (NCT07104604) | Affiliated Cancer Hospital of Shantou University Medical College | 2025-10-20 |
| Neoadjuvant Therapy （NALIRIFOX） for Locally Advanced Colon and Upper Rectal Cancer (NCT07020468) | Affiliated Cancer Hospital of Shantou University Medical College | 2025-05-15 |
| Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma (NCT05984342) | Affiliated Cancer Hospital of Shantou University Medical College | 2023-08-02 |
| Effect of Tramadol on Postoperative Sore Throat After General Anesthesia (NCT04991493) | Affiliated Cancer Hospital of Shantou University Medical College | 2021-09-10 |
Track Affiliated Cancer Hospital of Shantou University Medical College automatically
Every clearance here is in the API, with alerts when new ones post.